Physician profile
Bess E Brackett
NPI 1043269491
$2,696.50
in general payments reported to CMS, 2019-2025
14 companies · $25.32 in 2025
The $25.32 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,007 · 2020: $99.79 · 2021: $175 · 2022: $1,273 · 2023: $116 · 2025: $25.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $141.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,173.23 | 2022 | |
| Kci USA, INC. | $874.55 | 2019 | |
| Next Science LLC | $140.43 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $116.37 | 2023 | Iovera |
| Zimmer Biomet Holdings, INC. | $80.78 | 2019 | |
| Merck Sharp & Dohme LLC | $54.81 | 2019-2021 | |
| Acell, INC. | $52.09 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $50.45 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $35.18 | 2020-2022 | |
| Ethicon US, LLC | $30.57 | 2022 | |
| Baxter Healthcare | $25.40 | 2020 | |
| Depuy Synthes Sales INC. | $25.32 | 2025 | Tfn-Advance |
| Baudax Bio INC. | $19.93 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bess Brackett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.